Plan5500

Nektar Therapeutics — Form 5500 filings & benefit plans

Form 5500 plan sponsor summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Nektar Therapeutics (EIN 94-3134940) is a plan sponsor located in San Francisco, CA with 4 reported benefit plan(s) in the loaded dataset. The latest loaded Form 5500 filing year is 2023.

Company overview (based on loaded 2023 public filings)

EIN
94-3134940
Location
San Francisco, CA
Loaded plans
4
Latest filing year
2023

This is a company / sponsor profile — aggregate totals across all of this employer's loaded plans. Open an individual plan below for its own full financial statement.

What stands out for Nektar Therapeutics

  • 4 loaded plans hold $133.6M in reported assets.
  • The largest, Nektar Therapeutics 401(K) Plan, holds 100% of this company's reported plan assets.
  • Plans cover 1,788 reported participants.
  • 1 of 4 plans report full financial statements.
  • 1 report Schedule C provider compensation.
Aggregate financials · 2023

Reported financial aggregate

Total reported net assets$133.6MSummed across loaded plans$133,625,116
Total reported assets$133.6M$133,625,116
Total reported participants1.8K1,788
Total reported liabilities$0

Reported net position

Reported assets = net assets + liabilities (summed)$133.6M total assets
Net assets$133.6MLiabilities$0
Contributions & income
Employer contributions$1.4M
Participant contributions$3.6M
Total income / additions$30.6M
Expenses & distributions
Benefits paid / distributions$17.6M
Total expenses$17.7M
Net increase / (decrease)$13M

Data coverage

Plans with financial statements1 / 4 (25%)
Plans with provider compensation1 / 4 (25%)

Totals sum the latest loaded 2023 public Form 5500 filing per plan for this company's plans — one filing per plan, so multiple years are never double-counted. Figures are reported values from loaded Schedule H / I (and Schedule C for provider compensation); fields a plan did not report are treated as missing, not zero. These are not audited or official totals.

Computed from loaded plans

Portfolio comparison

Largest plan share of assets100%Nektar Therapeutics 401(K) Plan
Participants per plan447Average across loaded plans
Loaded plans4
Ranked by reported assets

Largest loaded plans

Bars show each plan's reported end-of-year assets relative to the largest.

  1. 1
    Nektar Therapeutics 401(K) Plan$133.6M
    Plan #001 · 994 participants · 2023
  2. 2
    Nektar Therapeutics Employees Benefit Plannot reported in the loaded dataset
    Plan #502 · 370 participants · 2023
  3. 3
    Nektar Therapeutics Severance Benefit Plannot reported in the loaded dataset
    Plan #511 · 212 participants · 2023
  4. 4
    Nektar Therapeutics Change Of Control Severance Benefit Plannot reported in the loaded dataset
    Plan #514 · 212 participants · 2023

All loaded plans by assets → · By participants → · With financial statements → · With provider compensation →

EFAST2 filings

Latest loaded filings

Most recent loaded Form 5500 filings for Nektar Therapeutics. Open one for its full reported snapshot.

  1. 2023
    Nektar Therapeutics 401(K) Plan994 participants · 2Sch HSch C
    View filing →
  2. 2023
    Nektar Therapeutics Employees Benefit Plan370 participants · 2No schedules
    View filing →
  3. 2023
    Nektar Therapeutics Severance Benefit Plan212 participants · 2No schedules
    View filing →
  4. 2023
    Nektar Therapeutics Change Of Control Severance Benefit Plan212 participants · 2No schedules
    View filing →

What to inspect next

Frequently asked questions

How many benefit plans does Nektar Therapeutics report on Form 5500?
Nektar Therapeutics (EIN 94-3134940) reports 4 benefit plan(s) in the loaded Form 5500 dataset.
What is the EIN for Nektar Therapeutics?
The Employer Identification Number (EIN) reported for Nektar Therapeutics is 94-3134940.
What is the latest Form 5500 filing year for Nektar Therapeutics?
The latest loaded Form 5500 filing year for Nektar Therapeutics is 2023.

Related Form 5500 pages